Dianthus Therapeutics, Inc. /DE/

DNTH

—

Advanced chart & tools →

Dianthus Therapeutics, Inc. /DE/DNTH

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-4.20

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$2.04M

Net income

$-162.34M

Net margin

-7973.3%

Gross margin

—

Dividends & financials

Dianthus Therapeutics, Inc. /DE/ (DNTH) reported revenue of $2.04M and net income of $-162.34M, or $-4.20 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.